Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Archives of Virology|January 1, 1976
Growth inhibition of human lymphoblastoid Daudi cells in vitro by interferon preparationsJ Hilfenhaus, H Damm, H E Karges, et al.
Developments in Biological Standardization|January 1, 1978
A purified human diploid cell rabies vaccineM Majer, J Hilfenhaus, H Gruschkau, et al.
Infection and Immunity|August 1, 1983
Comparison of effects of adjuvants on efficacy of virion envelope herpes simplex virus vaccine against labial infection of BALB/c miceT A Thomson, J Hilfenhaus, H Moser, et al.
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|July 1, 1987
Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC)-rabies vaccine in manN Scheiermann, J Baer, J Hilfenhaus, et al.
Developments in Biological Standardization|January 1, 1985
Long term cultivation of Namalva cells for interferon production: stable cytogenetic markers for identification of cells in spite of drastic chromosomal variationF Wurm, G Polastri, J Hilfenhaus, et al.
Behring Institute Mitteilungen|June 1, 1986
Generation of human anti-rubella monoclonal antibodies from human hybridomas constructed with antigen-specific Epstein-Barr virus transformed cell linesJ Hilfenhaus, E J Kanzy, R Köhler, et al.
Developments in Biological Standardization|January 1, 1991
Inactivation of retroviruses in biologicals manufactured for human useJ Hilfenhaus, J P Gregersen, H Müller, et al.
Journal of Clinical Microbiology|January 1, 1981
Correlation of herpes simplex virus antibody titers and specific lymphocyte stimulation in adult blood donorsH Moser, F Behrens, R Ziegelmaier, et al.
Medical Microbiology and Immunology|January 1, 1990
Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2M Bröker, K J Abel, R Köhler, et al.
Journal of Medical Virology|March 1, 1992
Virus safety of human immunoglobulins: efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedureT Nowak, J P Gregersen, U Klockmann, et al.
Pageof 6